AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-006770 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,462
Total Value
$6,507.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Common Stock | โ | Jan 5, 2026 | Sale | 3,604 | $1.00 | $3,614.81 | 61,944 | Direct | โ | View Details | |
Chief Strategy Officer | Common Stock | โ | Jan 6, 2026 | Sale | 2,858 | $1.01 | $2,892.30 | 59,086 | Direct | โ | View Details |